fluphenazine has been researched along with Disease Models, Animal in 25 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reserpine treatment increased VCMs and decreased locomotor activity." | 5.39 | Effect of Hypericum perforatum on different models of movement disorders in rats. ( Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C, 2013) |
| "Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man." | 2.37 | Acute dystonia induced by neuroleptic drugs. ( Jenner, P; Marsden, CD; Rupniak, NM, 1986) |
| "Wilson disease is a hereditary disorder caused by mutations of the ATP7B gene, which leads to intoxication with copper as a result of an unbalance of copper homeostasis." | 1.39 | [Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster]. ( Arcaya, JL; Salazar, U; Silva, EJ; Tejeda, CM; Urdaneta, K; Varela, K, 2013) |
| "Reserpine treatment increased VCMs and decreased locomotor activity." | 1.39 | Effect of Hypericum perforatum on different models of movement disorders in rats. ( Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C, 2013) |
| "Fluphenazine is a potent antipsychotic drug used to treat schizophrenia and other psychotic symptoms." | 1.35 | The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain. ( Cohen-Williams, M; Dong, XW; Hodgson, R; Jia, Y; Li, H; Lu, SX; Priestley, T; Zhou, X, 2008) |
| "The fluphenazine treatment produced VCMs in the majority of the treated rats (87% after 24 weeks)." | 1.34 | Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. ( Braga, AL; Calixto, JB; Fachinetto, R; Ferreira, J; Paixão, MW; Pereira, RP; Puntel, RL; Rocha, JB; Villarinho, JG; Wagner, C, 2007) |
| "Hyperprolactinemia is a known side-effect of fluphenazine, a broad spectrum, long-acting phenothiazine known to be D2 dopamine receptor antagonist." | 1.32 | Antifertility effects of fluphenazine in adult male rats. ( Aleem, M; Balasinor, N; Choudhary, J; D'Souza, S; Gill-Sharma, MK; Juneja, HS; Padwal, V; Parte, P; Sethi, G, 2003) |
| "The neuroleptic-induced catalepsy was reversed by the classical anti-parkinsonian agent L-DOPA and by agents that function through dopamine systems such as d- and methamphetamine and the direct D2 receptor agonist quinpirole." | 1.28 | Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. ( Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM, 1990) |
| "In ongoing studies of chronic administration of neuroleptics to monkeys (Cebus apella) and rats, the regional distribution of glutamic acid decarboxylase (GAD) and brain levels of homovanillic acid were examined." | 1.27 | Experimental tardive dyskinesia. ( Gunne, LM; Häggström, JE, 1985) |
| "Haloperidol was given first in doses of 1." | 1.27 | Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. ( Domino, EF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Lu, Y | 1 |
| Zhou, Z | 1 |
| Mo, L | 1 |
| Guo, Q | 1 |
| Peng, X | 1 |
| Hu, T | 1 |
| Zhou, X | 2 |
| Ren, B | 1 |
| Xu, X | 1 |
| Arcaya, JL | 1 |
| Tejeda, CM | 1 |
| Salazar, U | 1 |
| Silva, EJ | 1 |
| Urdaneta, K | 1 |
| Varela, K | 1 |
| Reis, EM | 1 |
| Röpke, J | 1 |
| Busanello, A | 1 |
| Reckziegel, P | 1 |
| Leal, CQ | 1 |
| Wagner, C | 2 |
| Boligon, AA | 1 |
| Athayde, ML | 1 |
| Fachinetto, R | 2 |
| Li, J | 1 |
| Pak, SC | 1 |
| O'Reilly, LP | 1 |
| Benson, JA | 1 |
| Wang, Y | 1 |
| Hidvegi, T | 1 |
| Hale, P | 1 |
| Dippold, C | 1 |
| Ewing, M | 1 |
| Silverman, GA | 1 |
| Perlmutter, DH | 1 |
| Wooters, TE | 1 |
| Bardo, MT | 1 |
| McCormick, SE | 1 |
| Stoessl, AJ | 2 |
| Gill-Sharma, MK | 1 |
| Aleem, M | 1 |
| Sethi, G | 1 |
| Choudhary, J | 1 |
| Padwal, V | 1 |
| D'Souza, S | 1 |
| Balasinor, N | 1 |
| Parte, P | 1 |
| Juneja, HS | 1 |
| Villarinho, JG | 1 |
| Pereira, RP | 1 |
| Puntel, RL | 1 |
| Paixão, MW | 1 |
| Braga, AL | 1 |
| Calixto, JB | 1 |
| Rocha, JB | 1 |
| Ferreira, J | 1 |
| Dong, XW | 1 |
| Jia, Y | 1 |
| Lu, SX | 1 |
| Cohen-Williams, M | 1 |
| Hodgson, R | 1 |
| Li, H | 1 |
| Priestley, T | 1 |
| Domino, EF | 3 |
| Kovacic, B | 2 |
| Bárány, S | 1 |
| Häggström, JE | 2 |
| Gunne, LM | 2 |
| Sachdev, P | 1 |
| Saharov, T | 1 |
| Cathcart, S | 1 |
| Van Kampen, JM | 1 |
| Elliott, PJ | 2 |
| Close, SP | 2 |
| Walsh, DM | 2 |
| Hayes, AG | 2 |
| Marriott, AS | 2 |
| See, RE | 2 |
| Aravagiri, M | 1 |
| Ellison, GD | 1 |
| Weinstein, D | 1 |
| Ellison, G | 1 |
| Klawans, HL | 1 |
| Carvey, P | 1 |
| Tanner, CM | 1 |
| Goetz, CG | 1 |
| Rupniak, NM | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Rosengarten, H | 1 |
| Schweitzer, JW | 1 |
| Egawa, M | 1 |
| Friedhoff, AJ | 1 |
1 review available for fluphenazine and Disease Models, Animal
| Article | Year |
|---|---|
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease M | 1986 |
24 other studies available for fluphenazine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Topics: Amphotericin B; Animal Structures; Animals; Antifungal Agents; Antipsychotic Agents; Candida albican | 2019 |
[Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].
Topics: Age Factors; Animals; Copper Sulfate; Disease Models, Animal; Disease Progression; Dopamine Agents; | 2013 |
Effect of Hypericum perforatum on different models of movement disorders in rats.
Topics: Animals; Disease Models, Animal; Fluphenazine; Hypericum; Male; Mastication; Motor Activity; Movemen | 2013 |
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Animals, Genetically Modified; Antipsy | 2014 |
Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulan | 2011 |
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug | 2003 |
Antifertility effects of fluphenazine in adult male rats.
Topics: Animals; Disease Models, Animal; Dopamine Antagonists; Embryo Implantation; Female; Fertility; Fluph | 2003 |
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Benzene Derivatives; Disease Models, | 2007 |
The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluphenazin | 2008 |
Monkey models of tardive dyskinesia.
Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fl | 1983 |
Application of a primate model for tardive dyskinesia.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Histamine An | 1983 |
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Stre | 1982 |
The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Delayed-Action Preparations; Disease Models, Animal; Dy | 1999 |
Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, | 2000 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationsh | 1990 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; | 1990 |
Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors.
Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Disease Models, Animal; Dyskinesia, | 1989 |
Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1989 |
The pathophysiology of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disea | 1985 |
Experimental tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Corpus Striatum; Disease Models, Animal; Drug Evaluatio | 1985 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Thera | 1985 |
Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Disease Models, A | 1988 |